Test Price
2,800 AED✅ Home Collection Available
ALDH3A2 Gene Sjögren-Larsson Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ALDH3A2 لمتلازمة شوغرن-لارسون في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE‑Trusted Genetic Diagnostics
- 99.9% Diagnostic Sensitivity – Your blood sample is processed in our ISO 9001:2015‑certified laboratory (Cert: INT/EGQ/2509DA/3139), delivering حساسية تشخيصية 99.9% (Diagnostic Sensitivity) for ALDH3A2 variant detection.
- Premium Cold‑Chain Home Collection – Schedule a VIP mobile phlebotomy visit between 8 AM and 11 PM, with سلسلة تبريد معتمدة (ISO certified cold chain) preserving DNA integrity from your doorstep to our genomics centre.
- Post‑Test Clinical Guidance – A DHA‑licensed neurologist will deliver a telephonic interpretation of your results within 3‑4 weeks, outlining the next medical and family counselling steps.
- Insurance & Direct Billing – Confirm your coverage instantly via WhatsApp at +971 54 548 8731.
Test Overview & Technology Comparison
This next-generation sequencing (NGS) test fully decodes the ALDH3A2 gene, identifying pathogenic variants that cause Sjögren-Larsson syndrome—a rare neurocutaneous disorder marked by spasticity, intellectual disability, and congenital ichthyosis. يكشف هذا الفحص عن الطفرات المسببة لمتلازمة شوغرن-لارسون بدقة تتجاوز 99%، مما يدعم التشخيص المبكر والاستشارة الوراثية.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Precision | Comprehensive gene‑wide NGS (all exons + flanking introns) | Targeted mutation panel (limited hotspots) |
| Methodology | NGS (Illumina®) with bioinformatics‑verified variant calling | Sanger sequencing of single exons / small gene regions |
| Turnaround Time | 3 weeks (expedited analysis available) | 6–8 weeks (standard laboratory queues) |
| UAE Compliance | DHA‑licensed facility (License 9834453), Federal Decree‑Law No. 41/2024 ready | May lack local insurance pre‑approval |
Physician Insight & Safety Protocol
“As a DHA‑licensed neurologist practicing in Dubai, I see families seeking clarity when a child presents with delayed milestones and scaly skin. This ALDH3A2 NGS test can confirm Sjögren‑Larsson syndrome, but it must be interpreted together with a complete neurological exam and dermatology evaluation. Please do not initiate or discontinue any therapy based solely on this genetic result; always consult your treating specialist.”
– Dr. Prabhakar Reddy, DHA License No. 61713011
⚠️ Medication Warning:
Do not stop or modify prescription medications (e.g., antispasmodics, dermatological creams, or nutritional supplements) without your physician’s direct instruction. A genetic result alone does not replace ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Active febrile illness or systemic infection – postpone blood draw until fully recovered.
- Therapeutic anticoagulation (e.g., warfarin, heparin) – inform the phlebotomist; special handling required.
- Recent blood transfusion (< 4 weeks) may affect DNA purity; reschedule.
- If the individual is a minor, legal guardian consent is mandatory per UAE CDS Law 2026.
🚨 Seek emergency care immediately if sudden vision loss, intractable seizures, severe spasticity, or breathing difficulties develop—these are not typical side effects of the blood draw but may indicate progression of the underlying syndrome.
Patient FAQ & Clinical Guidance
1. What exactly does the ALDH3A2 gene test detect and how will it help my diagnosis?
This test identifies disease‑causing variants in the entire ALDH3A2 gene, confirming a clinical suspicion of Sjögren‑Larsson syndrome with 99.9% sensitivity. يكشف هذا التحليل عن الطفرات الجينية المسببة لمتلازمة شوغرن-لارسون بدقة تزيد عن 99.9%، مما يؤكد التشخيص السريري. The result directs neurologists and dermatologists toward tailored interventions such as early physical therapy, ophthalmological monitoring, and oral retinoid‑based skin management.
2. How is the sample collected and what should I do to prepare?
A standard venous blood draw is performed at your home; a mandatory pre‑ genetic counselling session will be arranged to document your family pedigree. تُجرى جلسة استشارة وراثية إلزامية قبل سحب العينة لتوثيق شجرة العائلة. No fasting is required, but you must disclose all medications (especially blood thinners) and any recent transfusions.
3. Is my genetic data kept confidential under UAE law?
Yes, your DNA and health information are protected by the UAE Personal Data Protection Law (PDPL) and stored on encrypted servers within the UAE. نعم، بياناتك الجينية محمية بموجب قانون حماية البيانات الشخصية الإماراتي وتُخزَّن على خوادم مشفرة داخل الدولة. Results are shared exclusively with the ordering physician and yourself; no third‑party access is permitted without explicit consent.
Legal & Regulatory Compliance: This service complies with Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic testing, UAE PDPL, and the CDS Law 2026 governing minors’ consent. Facility DHA License: 9834453. ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
For result‑based clinical interpretation or to verify insurance, contact us via WhatsApp +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians